Tarceva 150 mg (Erlotinib) – Targeted EGFR Inhibitor for Lung Cancer
Tarceva 150 mg, containing Erlotinib, is a highly effective targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) and, in some cases, metastatic pancreatic cancer. It belongs to the class of EGFR tyrosine kinase inhibitors, which work by blocking signals that help cancer cells grow and multiply.
Erlocent 150 mg is a well-known generic version offering the same therapeutic benefits at a more affordable cost. Both Tarceva and Erlocent are commonly prescribed in patients whose tumors test positive for EGFR mutations, as these patients respond particularly well to EGFR-targeted therapy.
⭐ How Erlotinib Works
Erlotinib targets the epidermal growth factor receptor (EGFR) found on cancer cells. By inhibiting EGFR signaling, it:
-
Slows tumor cell growth
-
Blocks cancer cell division
-
Reduces tumor spread (metastasis)
-
Improves treatment response and progression-free survival
This targeted approach offers better precision with fewer side effects compared to conventional chemotherapy.
⭐ Uses / Indications
1. Non-Small Cell Lung Cancer (NSCLC)
-
First-line therapy for EGFR mutation-positive lung cancer
-
Treatment for advanced or metastatic disease
-
Maintenance therapy after initial response
2. Pancreatic Cancer
-
Used in combination with other medications for selected patients
⭐ Benefits of Erlotinib 150 mg
-
Targeted action against EGFR-positive tumors
-
Helps slow disease progression
-
Suitable for long-term therapy in responsive patients
-
Oral tablet for convenient daily dosing
-
Improves lung cancer symptoms such as cough and breathing difficulty
⭐ How to Take
-
Standard dose: 150 mg once daily
-
Take on an empty stomach (1 hour before or 2 hours after meals)
-
Swallow tablet whole with water
-
Do not adjust the dose without consulting your oncologist
⭐ Possible Side Effects
Common, usually mild:
-
Rash
-
Diarrhea
-
Fatigue
-
Dry skin
-
Loss of appetite
Less common but serious:
-
Lung inflammation (interstitial lung disease)
-
Severe diarrhea or dehydration
-
Liver function abnormalities
Immediate medical attention is required if breathing difficulty or severe skin reaction occurs.
⭐ Who Should Use Tarceva / Erlocent
-
Adults diagnosed with EGFR-positive NSCLC
-
Patients not responding to standard chemotherapy
-
Those requiring oral, targeted therapy for lung cancer management
⭐ Storage Instructions
-
Store below 30°C
-
Keep away from moisture, heat, and direct light
-
Keep out of reach of children
